Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 12 Oct 2019 - 18 Oct 2019
STUDY TYPE:Human Studies, Pharmacology/Drug Development
PAIN TYPE:Migraine/Headache
DATE PUBLISHED: 2019 Nov
JOURNAL:Headache
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/31612482?dopt=Abstract
Volume:59
ISSUE:10
A phase 2, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab for the prevention of episodic migraine in Japanese patients was conducted.
